Navigation Links
FDA CONSUMER HEALTH INFORMATION - Limit Use of 80 mg Simvastatin
Date:6/8/2011

SILVER SPRING, Md., June 8, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) is recommending that the use of drugs containing 80 mg of simvastatin — the highest approved dose of the popular cholesterol-lowering statin — be sharply curtailed because of the risk of muscle injury.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA says this dose should only be used by patients who have been taking it for 12 months or longer without ill effect. If health care professionals find that patients now taking 40 mg of simvastatin aren't meeting their LDL cholesterol goal, FDA is advising them to choose a different statin rather than raising the simvastatin dose to 80 mg.

All statins, despite their proven benefit in lowering the risk of heart attacks and strokes, carry some risk of an injury called myopathy, characterized by unexplained muscle weakness or pain. But the risk is greater for patients who take the 80 mg doses of simvastatin, especially in the first year of treatment.

Learn more about the FDA's concerns about the risk of taking this high-dose statin at

http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm257884.htm

Sign up for e-mail notices of new FDA Consumer Updates at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9

View the FDA Consumer Update RSS feed at http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

Media Contact: Morgan Liscinsky, (301) 796-0397, morgan.liscinsky@fda.hhs.gov


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Community Pharmacists Endorse Bipartisan Pharmacy Competition and Consumer Choice Act
2. CVS Caremark Research Tailors Consumer Communications to Encourage Better Medication Behavior
3. CVS Caremark to Participate in the Citi Investment Research 2011 Global Consumer Conference
4. CVS Caremark Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
5. American Imaging Management Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
6. FDA CONSUMER HEALTH INFORMATION - Ten Tips to Prevent an Accidental Overdose
7. FDA CONSUMER HEALTH INFORMATION - FDA Warns: Beware of Bogus STD Products
8. FDA CONSUMER HEALTH INFORMATION - How to Dispose of Unused Medicines
9. Important Information for Atwater Carey First Aid Kit Consumers Regarding Triad Groups Povidone Iodine Prep Pads
10. FDA Consumer Health Information -- Expiration Dates Matter
11. FDA CONSUMER HEALTH INFORMATION - FDA Acts to Reduce Opioid Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market Research, the legal cannabis ... to $6.7 billion and can be expected to grow at a 27 ... from $6.7 billion in 2016, to $22.6 billion in 2021. This more ... cannabis without a doctor,s recommendation. Voters in California , ...
(Date:3/27/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... is pleased to announce it has received conditional approval ... TSX Venture Exchange.  Receiving the conditional ... significant achievements for Invictus-MD. Some of which include: ... Laboratories Inc. ("AB Labs"), a Licensed Producer under the ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... 2017 , ... EpiGentek , a Farmingdale, NY-based biotech ... methylation “gold rush” with their established portfolio of optimized assay kits that measure ... m6A , RNA methylation has received a new burst in interest as ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office accelerates ... National Capital has added 10 new sales professionals over the past 6 months and ... 15 additional new hires over the course of 2017. , “This new office ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 to ... responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To combat ... which proposes a tax on prescription opioids to fund drug rehabilitation and prevention ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce ... large subjects. The ELITE DXA has an active scan window, which is more than ... to fit in the scan area could not undergo an accurate total body bone density ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Digital Scientists, a ... to announce the opening of a Greenville, South Carolina location. The lab ... progress in Greenville. , “We’ve been working with South Carolina clients for years from ...
Breaking Medicine News(10 mins):